Alkermes
ALKS
#2350
Rank
NZ$14.18 B
Marketcap
NZ$84.41
Share price
2.05%
Change (1 day)
62.74%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): NZ$0.0005540

According to Alkermes's latest financial reports the company's current EPS (TTM) is NZ-$0.0000000000. In 2025 the company made an earnings per share (EPS) of NZ$2.68 a decrease over its 2024 EPS that were of NZ$4.06.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.0005540-99.98%
2025NZ$2.68-34.08%
2024NZ$4.063.72%
2023NZ$3.91-323.96%
2022NZ-$1.75220%
2021NZ-$0.55-57.19%
2020NZ-$1.28-44.38%
2019NZ-$2.29
2017NZ-$1.87-24.82%
2016NZ-$2.49-9.87%
2015NZ-$2.77660%
2014NZ-$0.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.56-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.60-3,567,802,533,542,780,416.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.23-8,142,500,972,776,665,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.96-12,826,240,470,391,562,240.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
NZ-$91.56 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$0.82-810,647,220,741,039,872.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel